Latest Insider Transactions at Blade Air Mobility, Inc. (BLDE)
This section provides a real-time view of insider transactions for Blade Air Mobility, Inc. (BLDE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Blade Air Mobility, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Blade Air Mobility, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 11
2024
|
Scott M Wunsch CEO, Trinity Air Medical |
SELL
Open market or private sale
|
Direct |
7,741
-2.64%
|
$15,482
$2.85 P/Share
|
|
Sep 11
2024
|
Robert S Wiesenthal Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
91,030
-1.3%
|
$182,060
$2.85 P/Share
|
|
Sep 11
2024
|
William A. Heyburn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
35,348
-2.51%
|
$70,696
$2.85 P/Share
|
|
Sep 11
2024
|
Amir Cohen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
4,891
-6.15%
|
$9,782
$2.85 P/Share
|
|
Sep 11
2024
|
Melissa M. Tomkiel President and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
34,018
-2.72%
|
$68,036
$2.85 P/Share
|
|
Aug 14
2024
|
William A. Heyburn Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+1.74%
|
$0
$0.18 P/Share
|
|
Aug 09
2024
|
Edward M Philip Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,826
+17.74%
|
-
|
|
Aug 09
2024
|
Susan M Lyne Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,826
+22.02%
|
-
|
|
Aug 09
2024
|
Kenneth B Lerer Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,826
+24.72%
|
-
|
|
Aug 09
2024
|
Eric Affeldt Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,826
+7.28%
|
-
|
|
Aug 09
2024
|
John Borthwick Director |
BUY
Grant, award, or other acquisition
|
Direct |
58,529
+17.6%
|
-
|
|
Aug 09
2024
|
Reginald Love Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,826
+28.88%
|
-
|
|
Aug 01
2024
|
Scott M Wunsch CEO, Trinity Air Medical |
BUY
Grant, award, or other acquisition
|
Direct |
17,811
+5.74%
|
-
|
|
Jun 13
2024
|
Melissa M. Tomkiel President and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
60,834
-4.64%
|
$121,668
$2.94 P/Share
|
|
Jun 13
2024
|
William A. Heyburn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
57,994
-4.02%
|
$115,988
$2.94 P/Share
|
|
Jun 13
2024
|
Robert S Wiesenthal Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
145,571
-2.04%
|
$291,142
$2.94 P/Share
|
|
Jun 13
2024
|
Seth J Bacon CEO, Trinity Air Medical |
SELL
Payment of exercise price or tax liability
|
Direct |
1,416
-0.41%
|
$2,832
$2.94 P/Share
|
|
Jun 13
2024
|
Amir Cohen Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,892
-5.8%
|
$9,784
$2.94 P/Share
|
|
Jun 10
2024
|
Melissa M. Tomkiel President and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,253
+0.78%
|
$0
$0.18 P/Share
|
|
Jun 10
2024
|
John Borthwick Director |
BUY
Open market or private purchase
|
Direct |
7,743
+8.46%
|
$15,486
$2.97 P/Share
|
|
Jun 10
2024
|
Amir Cohen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
11,008
-11.54%
|
$33,024
$3.05 P/Share
|
|
Jun 10
2024
|
Reginald Love Director |
BUY
Open market or private purchase
|
Direct |
5,091
+7.52%
|
$10,182
$2.98 P/Share
|
|
Jun 10
2024
|
William A. Heyburn Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+2.04%
|
$0
$0.18 P/Share
|
|
Apr 03
2024
|
William A. Heyburn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,552
-1.44%
|
$61,656
$3.28 P/Share
|
|
Apr 03
2024
|
Melissa M. Tomkiel President and General Counsel |
SELL
Open market or private sale
|
Direct |
22,836
-1.74%
|
$68,508
$3.28 P/Share
|
|
Apr 03
2024
|
Amir Cohen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
4,220
-4.24%
|
$12,660
$3.28 P/Share
|
|
Apr 03
2024
|
Robert S Wiesenthal Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
25,418
-0.35%
|
$76,254
$3.28 P/Share
|
|
Mar 19
2024
|
William A. Heyburn Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+3.06%
|
$0
$0.18 P/Share
|
|
Mar 18
2024
|
Melissa M. Tomkiel President and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
27,857
+2.08%
|
$0
$0.18 P/Share
|
|
Mar 15
2024
|
Melissa M. Tomkiel President and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
55,555
+2.11%
|
$0
$0.18 P/Share
|
|
Mar 14
2024
|
Robert S Wiesenthal Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
66,932
-0.92%
|
$133,864
$2.62 P/Share
|
|
Mar 14
2024
|
William A. Heyburn Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+1.78%
|
$0
$0.18 P/Share
|
|
Mar 14
2024
|
William A. Heyburn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
26,632
-1.93%
|
$53,264
$2.62 P/Share
|
|
Mar 14
2024
|
Melissa M. Tomkiel President and General Counsel |
SELL
Open market or private sale
|
Direct |
25,634
-2.04%
|
$51,268
$2.62 P/Share
|
|
Mar 14
2024
|
Seth J Bacon CEO, Trinity Air Medical |
SELL
Payment of exercise price or tax liability
|
Direct |
180
-0.05%
|
$540
$3.94 P/Share
|
|
Mar 14
2024
|
Seth J Bacon CEO, Trinity Air Medical |
SELL
Open market or private sale
|
Direct |
1,212
-0.35%
|
$2,424
$2.62 P/Share
|
|
Mar 13
2024
|
Robert S Wiesenthal Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
68,387
-0.94%
|
$136,774
$2.76 P/Share
|
|
Mar 13
2024
|
Amir Cohen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
8,057
-3.81%
|
$16,114
$2.69 P/Share
|
|
Mar 13
2024
|
William A. Heyburn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
27,210
-1.93%
|
$54,420
$2.76 P/Share
|
|
Mar 13
2024
|
Melissa M. Tomkiel President and General Counsel |
SELL
Open market or private sale
|
Direct |
26,191
-2.04%
|
$52,382
$2.76 P/Share
|
|
Mar 13
2024
|
Seth J Bacon CEO, Trinity Air Medical |
SELL
Open market or private sale
|
Direct |
1,239
-0.36%
|
$2,478
$2.76 P/Share
|
|
Mar 08
2024
|
Robert S Wiesenthal Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,672
+0.62%
|
-
|
|
Mar 08
2024
|
Seth J Bacon CEO, Trinity Air Medical |
BUY
Grant, award, or other acquisition
|
Indirect |
676,029
+40.08%
|
-
|
|
Mar 08
2024
|
Seth J Bacon CEO, Trinity Air Medical |
BUY
Grant, award, or other acquisition
|
Direct |
260,035
+42.99%
|
-
|
|
Mar 08
2024
|
Amir Cohen Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,525
+7.34%
|
-
|
|
Mar 08
2024
|
Melissa M. Tomkiel President and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
22,836
+1.75%
|
-
|
|
Mar 08
2024
|
William A. Heyburn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,552
+1.44%
|
-
|
|
Jan 02
2024
|
Melissa M. Tomkiel President and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
30,148
+2.34%
|
$0
$0.18 P/Share
|
|
Jan 02
2024
|
William A. Heyburn Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
57,686
+3.99%
|
$0
$0.18 P/Share
|
|
Dec 15
2023
|
Melissa M. Tomkiel President and General Counsel |
SELL
Open market or private sale
|
Direct |
6,537
-0.53%
|
$19,611
$3.22 P/Share
|